Maximising leadership coaching training outcomes: A randomised controlled trial
International Journal of Evidence Based Coaching and Mentoring · 2023-08 · 21 (2) · 146-161
DOI: 10.24384/cwrs-bv43 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift International Journal of Evidence Based Coaching and Mentoring, 2023-08. Verfasst von Rae Rafferty und 2 weiteren Autor:innen. Die Arbeit wurde bisher 6-mal zitiert (Crossref).
Abstract (Originalsprache)
Nurse leaders manage complex workplace demands. Coaching skills are a core leadership competency which can assist them in their roles. However, training alone may not always effect positive leadership change. This randomised trial sought to compare outcomes of leadership coaching training, with and without follow-up support, against waitlist control. Psychometric and professional achievement outcomes for 86 Australian nurse leaders were tracked for six months. Trial results provide empirical support for the hypothesis that leadership coaching training, paired with coaching follow-up, yields superior outcomes to a training only approach and, versus control, in terms of leadership and communication-related outcomes.
Schlagwörter
Zitieren
APA
Rafferty, R., Fairbrother, G., & Cashin, A. (2023). Maximising leadership coaching training outcomes: A randomised controlled trial. International Journal of Evidence Based Coaching and Mentoring, 21(2), 146-161. https://doi.org/10.24384/cwrs-bv43
Vancouver
Rafferty R, Fairbrother G, Cashin A. Maximising leadership coaching training outcomes: A randomised controlled trial. International Journal of Evidence Based Coaching and Mentoring. 2023;21(2):146-161. doi:10.24384/cwrs-bv43
BibTeX
@article{Rafferty2023,
author = {Rafferty, Rae and Fairbrother, Greg and Cashin, Andrew},
title = {Maximising leadership coaching training outcomes: A randomised controlled trial},
journal = {International Journal of Evidence Based Coaching and Mentoring},
year = {2023},
volume = {21},
number = {2},
pages = {146--161},
doi = {10.24384/cwrs-bv43}
}
EUVIMED